Sanofi | CIK:0001121404 | 3

  • Filed: 3/16/2018
  • Entity registrant name: Sanofi (CIK: 0001121404)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/0001193125-18-084834-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1121404/000119312518084834/sny-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001121404
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory

    Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. The principal characteristics of those plans are as follows:

     

        2017     2016     2015  
    Type of plan   Performance
    share plan
       

    Performance

    share plan

       

    Performance

    share plan

     
    Date of Board meeting approving the plan     May 10, 2017       May 4, 2016       June 24, 2015  
    Total number of shares awarded     3,587,465       4,097,925       3,832,840  
    Of which plans subject to a 4-year service period     -       -       2,546,420  
    Fair value per share awarded(a)     -       -       79.52  
    Of which plans subject to a 3-year service period     3,587,465       4,097,925       1,286,420  
    Fair value per share awarded(a)     81.50       61.06       82.96  
    Fair value of plan at the date of grant ( million)     292       250       309  

     

      (a)

    Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period.